Irhythm Holdings Inc Revenue Growth Rates (IRTC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Irhythm Holdings Inc   (NASDAQ: IRTC)
 

IRTC's Revenue Growth by Quarter and Year

Irhythm Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/IRTC/growth
https://api.csimarket.com/api/v1/companies/IRTC/fundamentals
https://api.csimarket.com/api/v1/companies/IRTC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
IRTC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 221.59
2nd Quarter June 224.17
1st Quarter March 199.35
FY 645.11

IRTCs Annual Revenue
Irhythm Holdings Inc 's Revenue in the fiscal year 2025 $ 746.25 millions
Irhythm Holdings Inc 's Revenue in the fiscal year 2024 $ 591.53 millions
Irhythm Holdings Inc 's Revenue in the fiscal year 2023 $ 491.81 millions
Irhythm Holdings Inc 's Revenue in the fiscal year 2022 $ 410.92 millions
Irhythm Holdings Inc 's Revenue in the fiscal year 2021 $ 322.83 millions




IRTC Revenue third quarter 2026 Y/Y Growth Comment
Irhythm Holdings Inc reported Revenue increase of 15.34% year on year in the third quarter 2026, to $ 221.59 millions, this is lower than Irhythm Holdings Inc 's recent average Revenue improvement of 36.3%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 60 other companies have achieved higher Revenue growth. While Irhythm Holdings Inc ' s Revenue growth of 15.34% ranks overall at the positon no. 1011 in the third quarter 2026.


IRTC Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 15.34 %
2nd Quarter June 20.61 %
1st Quarter March 26 %
FY   -

Financial Statements
Irhythm Holdings Inc 's third quarter 2026 Revenue $ 221.59 millions IRTC's Income Statement
Irhythm Holdings Inc 's third quarter 2025 Revenue $ 192.12 millions Quarterly IRTC's Income Statement


IRTC Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -1.15 %
2nd Quarter June 12.45 %
1st Quarter March -5.1 %
FY (Year on Year)   -


Back to IRTC Growth rate Comparisons >> Back to IRTC Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #61
Healthcare Sector #202
Overall #1011

Revenue Y/Y Growth Statistics
High Average Low
82.2 % 36.3 % -4.6 %
(Dec 31 2016)   (Jun 30 2022)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #61
Healthcare Sector #202
Overall #1011
Revenue Y/Y Growth Statistics
High Average Low
82.2 % 36.3 % -4.6 %
(Dec 31 2016)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Irhythm Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
41.4 % 8.4 % -19.92 %
(Sep 30 2020)  


IRTC's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Irhythm Holdings Inc disclosed decrease in Revenue from the second quarter by -1.15% to $ 221.59 millions, from $ 224.17 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Irhythm Holdings Inc 's Revenue growth quarter on quarter, overall rank is 718.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #119
Overall #718
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #119
Overall #718
Revenue Q/Q Growth Statistics
High Average Low
41.4 % 8.4 % -19.92 %
(Sep 30 2020)  


IRTC's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Irhythm Holdings Inc disclosed decrease in Revenue from the second quarter by -1.15% to $ 221.59 millions, from $ 224.17 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Irhythm Holdings Inc 's Revenue growth quarter on quarter, overall rank is 718.


Irhythm Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 825.70
Y / Y Revenue Growth (TTM) 25.75 %
Year on Year Revenue Growth Overall Ranking # 761
Seqeuential Revenue Change (TTM) 4.87 %
Seq. Revenue Growth (TTM) Overall Ranking # 1943


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Irhythm Holdings Inc 's cumulative twelve months Revenue were $ 826 millions, company would post below average annual Revenue growth of 4.87% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Irhythm Holdings Inc 's Revenue growth from the 224.17% growth in Mar 31 2026.

In the Healthcare sector 155 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 322 to 761.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 110
Healthcare Sector # 156
Overall # 761

Revenue TTM Y/Y Growth Statistics
High Average Low
77.29 %
 34.59 %
18.06 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 110
Sector # 301
S&P 500 # 1943
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Irhythm Holdings Inc 's cumulative twelve months Revenue were $ 826 millions, company would post below average annual Revenue growth of 18.06% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Irhythm Holdings Inc 's Revenue growth from the 224.17% growth in Mar 31 2026.

In the Healthcare sector 155 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 322 to 761.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 110
Healthcare Sector # 156
Overall # 761

Revenue TTM Y/Y Growth Statistics
High Average Low
77.29 %
34.59 %
18.06 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 110
Sector # 301
S&P 500 # 1943




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
IRTC's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Vericel Corporation26.47%$ 26.470 millions
Axogen inc 26.22%$ 26.218 millions
Cardio Diagnostics Holdings Inc 25.74%$ 25.744 millions
Edap Tms Sa25.55%$ 25.549 millions
Lifestance Health Group Inc 25.30%$ 25.303 millions
Rockwell Medical inc 25.21%$ 25.210 millions
Intelligent Bio Solutions Inc 25.19%$ 25.188 millions
The Oncology Institute Inc 24.31%$ 24.313 millions
Vanda Pharmaceuticals Inc 24.10%$ 24.098 millions
Mannkind Corporation24.04%$ 24.035 millions
Castle Biosciences Inc 23.90%$ 23.901 millions
Coherus Oncology inc 23.36%$ 23.360 millions
Prestige Consumer Healthcare Inc 22.93%$ 22.929 millions
Acadia Pharmaceuticals Inc 22.85%$ 22.847 millions
Protalix Biotherapeutics inc 22.82%$ 22.822 millions
Atrium Therapeutics Inc 22.81%$ 22.814 millions
Capsovision Inc 22.44%$ 22.443 millions
Veracyte Inc 22.10%$ 22.105 millions
Radnet Inc 22.07%$ 22.068 millions
Alkermes Plc 21.80%$ 21.804 millions
Alpha Teknova Inc 21.52%$ 21.523 millions
Anteris Technologies Global Corp 20.98%$ 20.979 millions
Trisalus Life Sciences Inc 20.81%$ 20.807 millions
Orthopediatrics Corp20.55%$ 20.551 millions
Alpha Pro Tech Ltd 19.73%$ 19.729 millions
Insulet Corporation19.21%$ 19.213 millions
Abcellera Biologics Inc 18.81%$ 18.805 millions
Schrodinger Inc 18.72%$ 18.715 millions
Procept Biorobotics Corporation18.41%$ 18.414 millions
Supernus Pharmaceuticals inc 18.05%$ 18.047 millions


About Irhythm Holdings Inc Revenue Growth Rates (IRTC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Irhythm Holdings Inc (CIK 1388658).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001388658-26-000094
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Irhythm Holdings Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.